daunorubicin has been researched along with Cutaneous T-Cell Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alonso-Llamazares, J; Marchione, R; Ricotti, C; Romanelli, P; Shiman, M | 1 |
Haroske, E; Hohaus, K; Köstler, E; Schönlebe, J; Wollina, U | 1 |
1 review(s) available for daunorubicin and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pruritus; Remission Induction; Vincristine | 2008 |
1 other study(ies) available for daunorubicin and Cutaneous T-Cell Lymphoma
Article | Year |
---|---|
Liposomal daunorubicin in tumor stage cutaneous T-cell lymphoma: report of three cases.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administration Schedule; Female; Humans; Liposomes; Lymphoma, T-Cell, Cutaneous; Male; Treatment Outcome | 2003 |